Response Genetics, Inc (RGDX) Stock Research, Analysis & News

Quick Analysis on Response Genetics, Inc (RGDX) Stock as of June 19, 2018

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Response Genetics, Inc (RGDX) Stock below)

Response Genetics, Inc (RGDX) Stock Profile Summary

Response Genetics, Inc., a life sciences company, engages in the research, development, marketing, and sale of clinical diagnostics and pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and Japan. It offers ResponseDX: Lung test suites for non-small cell lung cancer; ResponseDX: Colon test suites for colorectal cancer; and ResponseDX: Gastric test suites for gastric and gastroesophageal cancer. The companys Response DX test measures the RNA expression of ERCC1, TS, and RRM1 through reverse transcription polymerase chain reaction analysis from a patient's tumor tissue; and polymerase chain reaction analysis of DNA from the patient's sample to determine EGFR amplification, as well as BRAF, EGFR, and KRAS mutational status. It is also developing tests for other types of cancer that identify genetic profiles of tumors that recur after surgery. The company offers its products through its sales force to community based oncologists, hospitals, and physician offices. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California.

Response Genetics, Inc (RGDX) Stock Key Statistics Research and Analysis as of June 19, 2018

Response Genetics, Inc (RGDX) Stock Competitor Research and Analysis

Clinical Data, Inc. (CLDA)Genomic Health Inc. (GHDX)
Quest Diagnostics Inc. (DGX)

Latest Market News on Response Genetics, Inc (RGDX)

Click here to find the latest news on Response Genetics, Inc (RGDX)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Clinical Data, Inc. (CLDA)
Genomic Health Inc. (GHDX)
Quest Diagnostics Inc. (DGX)